Menu
/REGISTER
Montecito
Giving Guide
PacPremier
Loading...
You are here:  Home  >  'genetics'
Latest

Santa Maria ag forum focuses on challenges

By   /  Friday, February 14th, 2020  /  Agribusiness, Central Coast, Latest news, Wine & Viticulture  /  Comments Off on Santa Maria ag forum focuses on challenges

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen donations to CSUCI developing STEM ecosystem

By   /  Friday, December 14th, 2018  /  Biotech, Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on Amgen donations to CSUCI developing STEM ecosystem

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen buys $66 million stake in genetics device company

By   /  Thursday, October 18th, 2018  /  East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen buys $66 million stake in genetics device company

Thousand Oaks biotech giant Amgen broadened its reach into genetics research Oct. 18 with a $66 million investment in handheld DNA sequencing company Oxford Nanopore Technologies. Genetics has been a research focus for Amgen since its 2012 acquisition of deCODE, particularly in the area of Alzheimer’s therapies. The news follows closely the release by Oxford Read More →

Read More →
Latest

Amgen studying genes to target pain conditions

By   /  Monday, October 16th, 2017  /  Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen studying genes to target pain conditions

For the next year, Amgen and Boston Children’s Hospital will use genetic analysis to study pain sensitivity. The biotech giant based in Thousand Oaks will work with patients who have abnormal pain conditions, and the hospital will validate genetic markers as potential targets for new therapies, the two announced in a press release on Oct. 16. “Traditional Read More →

Read More →
Latest

Amgen buys DeCode Genetics for $415M

By   /  Monday, December 10th, 2012  /  Banking & Finance, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen buys DeCode Genetics for $415M

Biotech giant Amgen is buying Icelandic genetics research firm DeCode Genetics for $415 million, the Thousand Oaks company said Dec. 10. The all-cash deal is expected to close before the end of the year and will give Amgen, the largest biotechnology firm in the world, opportunities to develop new medicines that target defective DNA. “DeCode Read More →

Read More →